SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-009219
Filing Date
2018-05-09
Accepted
2018-05-09 16:45:07
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20180331_10q.htm 10-Q 927524
2 EXHIBIT 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex_113382.htm EX-31.1 12482
3 EXHIBIT 31.2 CERTIFICATION OF CHIEF FIANCIAL OFFICER ex_113383.htm EX-31.2 13130
4 EXHIBIT 32.1 CERTIFICATION OF PERIODIC REPORT ex_113384.htm EX-32.1 8340
5 EXHIBIT 32.2 CERTIFICATION OF PERIODIC REPORT ex_113385.htm EX-32.2 6922
  Complete submission text file 0001437749-18-009219.txt   4499997

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20180331.xml EX-101.INS 1033850
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20180331.xsd EX-101.SCH 42404
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20180331_cal.xml EX-101.CAL 39791
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20180331_def.xml EX-101.DEF 275969
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20180331_lab.xml EX-101.LAB 240463
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20180331_pre.xml EX-101.PRE 293583
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 18818982
SIC: 2834 Pharmaceutical Preparations